Evidence map›Paper›PMID 40599936›Full record

ArticleBioinformation2025

Molecular docking analysis of bioactive molecules from herbs with snake venom phospholipase A2.

Karthik Nagarajan S, Siva Annamalai, Bharath Christian C B S, Rajamaheswari K, Lavanya A, Arunachalam K

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioinformation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Karthik Nagarajan SDepartment of Clinical, National Institute of Siddha, Chennai, India.
Siva AnnamalaiDepartment of Clinical, Siddha Regional Research Institute, Puducherry, India.
Bharath Christian C B SDepartment of Clinical, National Institute of Siddha, Chennai, India.
Rajamaheswari KDepartment of Clinical, National Institute of Siddha, Chennai, India.
Lavanya ADepartment of Clinical, National Institute of Siddha, Chennai, India.
Arunachalam KDepartment of Clinical, Siddha Clinical Research Unit, Tirupati, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Snake venom, particularly phospholipase A2 (PLA2), exerts profound pathological effects, necessitating the development of potent therapeutic interventions. Therefore, it is of interest to the inhibitory potential of bioactive phytoconstituents from select medicinal herbs with PLA2. Analysis showed that Gymnemic acid, Aristolochic acid, Lupeol and Tocopherol are the best PLA2 inhibitors with strong binding and molecular interactions for further consideration.

Indexed as

Molecular dockingnetwork pharmacologyphospholipase A2

Identifiers

PMID40599936
PMCPMC12208267

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.